Pharma Equity Group A/S reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was DKK 2.86 million compared to DKK 2.11 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.242 DKK | +1.68% |
|
+0.83% | -43.72% |
05-17 | Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-16 | Pharma Equity Group A/S Maintains Group Earnings Guidance for the Full Year of 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-43.72% | 35.61M | |
+23.76% | 84.26B | |
+10.03% | 17.63B | |
+57.40% | 17.21B | |
+10.43% | 14.94B | |
-3.59% | 12.52B | |
+12.48% | 11.68B | |
-0.18% | 11.01B | |
+28.43% | 10.08B | |
+73.38% | 8.86B |
- Stock Market
- Equities
- PEG A Stock
- News Pharma Equity Group A/S
- Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2023